HPBCD accesses acute and subacute infarcts in a mouse model of ischemic stroke
Ischemic stroke is a leading cause of mortality and long-term disability worldwide, with limited pharmacological interventions available. Researchers in Arizona
Tag: fluorescent labeling
Novel fluorescent CD as theranostic platform for anticancer agents delivery
A novel β-cyclodextrin-aza[5]helicene conjugate as theranostic platform for anticancer agents delivery in cancer cells is reported. The carrier was synthesized
Cellular Effects of Cyclodextrins: Studies on Caco-2 and HeLa Cells
In this work the cellular internalization and the intracellular effects of (2-hydroxypropyl)-beta (HPBCD) and random methyl-beta cyclodextrin (RAMEB) on Caco-2